Italy - Italian - AIFA (Agenzia Italiana del Farmaco)

pharmacare s.r.l. - metformina - metformina

Italy - Italian - AIFA (Agenzia Italiana del Farmaco)

inventia healthcare bv - metformina - metformina

Italy - Italian - AIFA (Agenzia Italiana del Farmaco)

doc generici srl - metformina - metformina

Italy - Italian - AIFA (Agenzia Italiana del Farmaco)

eg s.p.a. - metformina - metformina

Italy - Italian - AIFA (Agenzia Italiana del Farmaco)

galenicum health, s.l. - metformina e sitagliptina - metformina e sitagliptina

Italy - Italian - AIFA (Agenzia Italiana del Farmaco)

doc generici srl - metformina e sitagliptina - metformina e sitagliptina

Italy - Italian - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - metformina e vildagliptin - metformina e vildagliptin

Italy - Italian - AIFA (Agenzia Italiana del Farmaco)

krka d.d. novo mesto - metformina e vildagliptin - metformina e vildagliptin

Italy - Italian - AIFA (Agenzia Italiana del Farmaco)

eg s.p.a. - metformina e pioglitazone - metformina e pioglitazone

European Union - Italian - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).